It may not even be the one-in-10,000 risk of irreversible paralysis known as subacute sclerosing panencephalitis, which is ...

Johns Hopkins Medicine laboratory scientists say they have developed a potential new way to treat a variety of rare genetic ...

The antibodies attach to a part of the virus that doesn't appear to mutate, potentially allowing them to work on multiple COVID-19 variants.

Mikael Dolsten, M.D., Ph.D., to its Board of Directors. Dolsten, who served as Pfizer’s chief scientific officer and president of research and development for 15 years, will support Immunai’s efforts ...

WASHINGTON, March 8 (Reuters) - The Trump administration rescinded a waiver on Saturday that had allowed Iraq to pay Iran for electricity, as part of President Donald Trump's "maximum pressure ...

NEW YORK (AP) — It took five years for Crystal Burke to put a name to the symptoms that haunted her. Heart palpitations. Insomnia so severe she slept only two to four hours a night. A newfound ...

Researchers from SRM Institute of Science and Technology, led by Dr. KN Aruljothi, have published a study in ExRNA highlighting the role of exosomal RNA (exRNA) in head and neck cancers (HNCs).

To boost those proteins, they’ve created experimental versions of a genetic “tail” that attaches to so-called mRNA molecules that churn out the proteins. A report on the researchers’ proof ...

This review explores recent advancements in dengue vaccine development, emphasizing potential utility of mRNA-based vaccines. By examining current clinical trial data and innovations, we aim to ...

The strangely adorable and resilient tardigrade, or water bear, just might hold the key to making cancer treatment a lot more (water-) bearable. That’s because a team of researchers just found ...